vs

Side-by-side financial comparison of ENTEGRIS INC (ENTG) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

ENTEGRIS INC is the larger business by last-quarter revenue ($823.9M vs $510.9M, roughly 1.6× Genius Sports Ltd). ENTEGRIS INC runs the higher net margin — 6.0% vs -12.3%, a 18.3% gap on every dollar of revenue. ENTEGRIS INC produced more free cash flow last quarter ($134.0M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 3.4%).

Entegris, Inc. is a supplier of materials for the semiconductor and other high-tech industries. Entegris has approximately 8,000 employees throughout its global operations. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. The company’s corporate headquarters are in Billerica, Massachusetts.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

ENTG vs GENI — Head-to-Head

Bigger by revenue
ENTG
ENTG
1.6× larger
ENTG
$823.9M
$510.9M
GENI
Higher net margin
ENTG
ENTG
18.3% more per $
ENTG
6.0%
-12.3%
GENI
More free cash flow
ENTG
ENTG
$64.4M more FCF
ENTG
$134.0M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
3.4%
ENTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ENTG
ENTG
GENI
GENI
Revenue
$823.9M
$510.9M
Net Profit
$49.4M
$-63.0M
Gross Margin
43.8%
25.2%
Operating Margin
12.7%
-11.5%
Net Margin
6.0%
-12.3%
Revenue YoY
-3.1%
Net Profit YoY
-51.7%
EPS (diluted)
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENTG
ENTG
GENI
GENI
Q4 25
$823.9M
$510.9M
Q3 25
$807.1M
$335.4M
Q2 25
$792.4M
$215.2M
Q1 25
$773.2M
$119.7M
Q4 24
$849.8M
$413.0M
Q3 24
$807.7M
$285.8M
Q2 24
$812.7M
$184.1M
Q1 24
$771.0M
$97.2M
Net Profit
ENTG
ENTG
GENI
GENI
Q4 25
$49.4M
$-63.0M
Q3 25
$70.5M
Q2 25
$52.8M
$-47.3M
Q1 25
$62.9M
$-25.5M
Q4 24
$102.2M
$-85.5M
Q3 24
$77.6M
$-47.1M
Q2 24
$67.7M
$-35.5M
Q1 24
$45.3M
$-25.2M
Gross Margin
ENTG
ENTG
GENI
GENI
Q4 25
43.8%
25.2%
Q3 25
43.5%
24.2%
Q2 25
44.4%
19.1%
Q1 25
46.1%
10.7%
Q4 24
45.6%
16.7%
Q3 24
46.0%
20.5%
Q2 24
46.2%
18.6%
Q1 24
45.6%
9.8%
Operating Margin
ENTG
ENTG
GENI
GENI
Q4 25
12.7%
-11.5%
Q3 25
15.2%
-15.3%
Q2 25
13.4%
-21.0%
Q1 25
15.8%
-20.3%
Q4 24
17.6%
-18.0%
Q3 24
16.9%
-13.9%
Q2 24
16.0%
-16.8%
Q1 24
15.3%
-23.7%
Net Margin
ENTG
ENTG
GENI
GENI
Q4 25
6.0%
-12.3%
Q3 25
8.7%
Q2 25
6.7%
-22.0%
Q1 25
8.1%
-21.3%
Q4 24
12.0%
-20.7%
Q3 24
9.6%
-16.5%
Q2 24
8.3%
-19.3%
Q1 24
5.9%
-25.9%
EPS (diluted)
ENTG
ENTG
GENI
GENI
Q4 25
$0.33
Q3 25
$0.46
Q2 25
$0.35
Q1 25
$0.41
Q4 24
$0.67
Q3 24
$0.51
Q2 24
$0.45
Q1 24
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENTG
ENTG
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$360.4M
$280.6M
Total DebtLower is stronger
$3.7B
Stockholders' EquityBook value
$4.0B
$724.5M
Total Assets
$8.4B
$1.1B
Debt / EquityLower = less leverage
0.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENTG
ENTG
GENI
GENI
Q4 25
$360.4M
$280.6M
Q3 25
$399.8M
$110.2M
Q2 25
$376.8M
$110.2M
Q1 25
$340.9M
$110.2M
Q4 24
$329.2M
$100.3M
Q3 24
$432.1M
$100.3M
Q2 24
$320.0M
$100.3M
Q1 24
$340.7M
$100.3M
Total Debt
ENTG
ENTG
GENI
GENI
Q4 25
$3.7B
Q3 25
$3.8B
Q2 25
$4.0B
Q1 25
$4.0B
Q4 24
$4.0B
Q3 24
$4.1B
Q2 24
$4.1B
Q1 24
$4.2B
Stockholders' Equity
ENTG
ENTG
GENI
GENI
Q4 25
$4.0B
$724.5M
Q3 25
$3.9B
$572.4M
Q2 25
$3.8B
$572.4M
Q1 25
$3.7B
$572.4M
Q4 24
$3.7B
$573.0M
Q3 24
$3.6B
$573.0M
Q2 24
$3.5B
$573.0M
Q1 24
$3.4B
$573.0M
Total Assets
ENTG
ENTG
GENI
GENI
Q4 25
$8.4B
$1.1B
Q3 25
$8.4B
$792.3M
Q2 25
$8.4B
$792.3M
Q1 25
$8.4B
$792.3M
Q4 24
$8.4B
$775.7M
Q3 24
$8.5B
$775.7M
Q2 24
$8.3B
$775.7M
Q1 24
$8.4B
$775.7M
Debt / Equity
ENTG
ENTG
GENI
GENI
Q4 25
0.94×
Q3 25
0.99×
Q2 25
1.05×
Q1 25
1.06×
Q4 24
1.08×
Q3 24
1.15×
Q2 24
1.18×
Q1 24
1.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENTG
ENTG
GENI
GENI
Operating Cash FlowLast quarter
$192.0M
$81.9M
Free Cash FlowOCF − Capex
$134.0M
$69.6M
FCF MarginFCF / Revenue
16.3%
13.6%
Capex IntensityCapex / Revenue
7.0%
2.4%
Cash ConversionOCF / Net Profit
3.89×
TTM Free Cash FlowTrailing 4 quarters
$396.2M
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENTG
ENTG
GENI
GENI
Q4 25
$192.0M
$81.9M
Q3 25
$249.5M
$-4.8M
Q2 25
$113.5M
$-1.2M
Q1 25
$140.4M
$-14.6M
Q4 24
$176.1M
$14.9M
Q3 24
$197.2M
$-9.2M
Q2 24
$111.2M
Q1 24
$147.2M
Free Cash Flow
ENTG
ENTG
GENI
GENI
Q4 25
$134.0M
$69.6M
Q3 25
$182.8M
$-14.2M
Q2 25
$47.0M
$-5.8M
Q1 25
$32.4M
$-16.0M
Q4 24
$68.6M
$11.3M
Q3 24
$115.0M
$-11.6M
Q2 24
$51.9M
Q1 24
$80.6M
FCF Margin
ENTG
ENTG
GENI
GENI
Q4 25
16.3%
13.6%
Q3 25
22.6%
-4.2%
Q2 25
5.9%
-2.7%
Q1 25
4.2%
-13.4%
Q4 24
8.1%
2.7%
Q3 24
14.2%
-4.1%
Q2 24
6.4%
Q1 24
10.4%
Capex Intensity
ENTG
ENTG
GENI
GENI
Q4 25
7.0%
2.4%
Q3 25
8.3%
2.8%
Q2 25
8.4%
2.1%
Q1 25
14.0%
1.2%
Q4 24
12.7%
0.9%
Q3 24
10.2%
0.9%
Q2 24
7.3%
Q1 24
8.6%
Cash Conversion
ENTG
ENTG
GENI
GENI
Q4 25
3.89×
Q3 25
3.54×
Q2 25
2.15×
Q1 25
2.23×
Q4 24
1.72×
Q3 24
2.54×
Q2 24
1.64×
Q1 24
3.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENTG
ENTG

Fabs$516.3M63%
Equipment And Engineering$121.8M15%
Chemical And Materials$83.8M10%
Other$61.7M7%
Non Semi$40.3M5%

GENI
GENI

Segment breakdown not available.

Related Comparisons